Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature Precedings
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • RSS feed
  1. nature
  2. nature precedings
  3. articles
  4. article
Inhibition of pteridine reductase 1 (PTR1) expression in Leishmania promastigotes using a full-length antisense construct
Download PDF
Download PDF
  • Manuscript
  • Open access
  • Published: 22 January 2009

Inhibition of pteridine reductase 1 (PTR1) expression in Leishmania promastigotes using a full-length antisense construct

  • Farnaz Kheirandish1,
  • Mojgan Bandehpour1,
  • Nushin Davoudi2,
  • Nariman Mosaffa1,
  • Fereydoun Mahboudi2,
  • Bahram Kazemi1,
  • Ali Haghighi1 &
  • …
  • Mehdi Mohebali3 

Nature Precedings (2009)Cite this article

  • 411 Accesses

  • Metrics details

Abstract

Leishmania exhibit many unusual features, one of which is the pteridine metabolic pathway essential for the growth for these parasites. Leishmania have evolved a complex and versatile pteridine salvage network capable of scavenging a wide array of conjugated and unconjugated pteridines. The L. major PTR1 gene was cloned into pcDNA3 digested with KpnI and BamHI. The gene was cloned antiparallel to the promoter and named pcDNA-Rptr. L. major promastigotes were divided into two groups. One group was transfected with 50 &x03BC;g of pcDNA-Rptr, whereas the other group was electroporated with pcDNA3. Mentioned cells were cultured and plated onto semi-solid media.Western blotting was performed on extracts from transfected promastigotes of L. major using an leishmania major PTR1 antibody. The PTR1 protein was not expressed in pcDNA-Rptr-tansfected promastigotes, 'Our results indicate that our system may be useful for studying the pteridine salvage pathway in Leishmania as a possible drug target.

Similar content being viewed by others

Translational reprogramming as a driver of antimony-drug resistance in Leishmania

Article Open access 05 May 2023

Genomic characterization of Leishmania (V.) braziliensis associated with antimony therapeutic failure and variable in vitro tolerance to amphotericin B

Article Open access 15 April 2025

Systematic functional analysis of Leishmania protein kinases identifies regulators of differentiation or survival

Article Open access 23 February 2021

Article PDF

Author information

Authors and Affiliations

  1. Shahid Beheshti University, M.C., Tehran, Iran

    Farnaz Kheirandish, Mojgan Bandehpour, Nariman Mosaffa, Bahram Kazemi & Ali Haghighi

  2. Institute Pasteur of Iran, Tehran, Iran

    Nushin Davoudi & Fereydoun Mahboudi

  3. Tehran University of Medical Sciences, Tehran, Iran

    Mehdi Mohebali

Authors
  1. Farnaz Kheirandish
    View author publications

    Search author on:PubMed Google Scholar

  2. Mojgan Bandehpour
    View author publications

    Search author on:PubMed Google Scholar

  3. Nushin Davoudi
    View author publications

    Search author on:PubMed Google Scholar

  4. Nariman Mosaffa
    View author publications

    Search author on:PubMed Google Scholar

  5. Fereydoun Mahboudi
    View author publications

    Search author on:PubMed Google Scholar

  6. Bahram Kazemi
    View author publications

    Search author on:PubMed Google Scholar

  7. Ali Haghighi
    View author publications

    Search author on:PubMed Google Scholar

  8. Mehdi Mohebali
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Bahram Kazemi.

Rights and permissions

Creative Commons Attribution 3.0 License.

Reprints and permissions

About this article

Cite this article

Kheirandish, F., Bandehpour, M., Davoudi, N. et al. Inhibition of pteridine reductase 1 (PTR1) expression in Leishmania promastigotes using a full-length antisense construct. Nat Prec (2009). https://doi.org/10.1038/npre.2009.2807.1

Download citation

  • Received: 20 January 2009

  • Accepted: 22 January 2009

  • Published: 22 January 2009

  • DOI: https://doi.org/10.1038/npre.2009.2807.1

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Leishmania
  • Antisense
  • ptr1
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Nature Precedings (Nat Preced)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing